F8 and renal cell carcinoma: However, the rapid onset of inhibitor formation within a week of transfusion, rather than a gradual immune response over months or years, supports FVIII replacement therapy as a likely cause as opposed to RCC, within which we would expect inhibitor development during active malignancy and resolution post-nephrectomy, neither of which occurred.